Dr. Stephen A. Cutler, Ph.D., is Group President Clinical Research Services of Icon PLC., since November 2011. Prior to joining the Company Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management Europe; and Vice President, Oncology Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles Dr. Cutler held positions with Sandoz in Australia and Europe. He holds a B.Sc. and a Ph.D from the University of Sydney and a Masters of Business Administration from the University of Birmingham .
Group President - Clinical Research Services
Age: 50 President Since 2011
The company has return on total asset (ROA) of 4.74 % which means that it generated profit of $4.74 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 8.91 % meaning that it created $8.91 on every $100 dollars invested by stockholders.
The company currently holds 20 M in liabilities with Debt to Equity (D/E) ratio of 0.03 which may suggest the company is not taking enough advantage from borrowing. ICON Public Limited Company has Current Ratio of 1.5 which is within standard range for the sector.
Entity SummaryICON Public Limited Company, a contract research organization, offer outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in Ireland, the United States, and rest of Europe. ICON Public Limited Company [ICLR] is traded on NASDAQ in USA. It is located in Dublin, and employs 10,200 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| ICLR Nasdaq
ICON Public Limited Company
ICON Public Limited Company has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
ICON price boundaries
Promote ICON and Stephen Cutler